Neuroprotection for Parkinson's disease: a new approach for a new millennium (Q34481778)

2 August 2017

1 reference

title

Neuroprotection for Parkinson's disease: a new approach for a new millennium (English)

1 reference

2 August 2017

1 reference

Drukarch B

1

1 reference

2 August 2017

van Muiswinkel FL

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1855-1868

1 reference

Etiology and pathogenesis of Parkinson's disease

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Therapeutic advances in idiopathic Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Success and problems of long-term levodopa therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Apoptosis modulators in the therapy of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Remacemide: current status and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Parkinson's disease: a major hypokinetic basal ganglia disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Parkinson's disease: prospects for improved drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Rasagiline [N-propargyl-1R( )-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Cytotoxic and genotoxic potential of dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Tyrosinase mRNA is expressed in human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Biochemical and toxicological properties of the oxidation products of catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

The oxidative metabolism of catecholamines in the brain: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Biosynthesis, Structure, and Function of Neuromelanin and its Relation to Parkinson's Disease: A Critical Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

The neuromelanin of the human substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Protection of intracellular dopamine cytotoxicity by dopamine disposition and metabolism factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

NADPH cytochrome P-450 reductase in rat, mouse and human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Overview of enzymes of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Detoxication Enzymes and Chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Preferential expression of superoxide dismutase messenger RNA in melanized neurons in human mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Chemical and molecular regulation of enzymes that detoxify carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

On the mechanisms of induction of cancer-protective enzymes: a unifying proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Chemoprotective 3H-1,2-dithiole-3-thione induces antioxidant genes in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Aryl hydrocarbon receptor-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Redox Regulation of Genes that Protect Against Carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Antioxidant response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Chemoprevention: increased potential to bear fruit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Anethole dithiolethione: biochemical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Metabolism of xenobiotics in the central nervous system: implications and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/13543784.10.10.1855

10.1517/13543784.10.10.1855

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference